Additional cases of ceftriaxone-non-susceptible gonorrhea in Massachusetts.

URI
Main Digital Collection
Digital Collection
Author(s)
Massachusetts. Department of Public Health. Division of STD Prevention.
Publisher
Massachusetts Department of Public Health, Bureau of Infectious Disease and Laboratory Sciences, Division of STD Prevention.
Date Issued
2025-09-25
Language
English (United States)
Type
Book
Abstract
"Two additional confirmed cases of ceftriaxone non-susceptible gonorrhea have been identified in Massachusetts in 2025. Because the vast majority of cases in Massachusetts are cephalosporin-susceptible, single dose ceftriaxone 500 mg IM remains the recommended first-line treatment for mucosal gonorrhea infections."--Highlights.
Organizations / Corporate Body
Massachusetts. Department of Public Health. Division of STD Prevention.
File(s)
Thumbnail Image
Name

on1613535707.pdf

Size

226.74 KB

Format

Adobe PDF

Checksum (MD5)

86f4ddfed9bb2bdcb97ee02415386963